Skip to main content
HCPCS J2545 · Level II · Part B drug

J2545: pentamidine isethionate (Nebupent), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J2545

Billing unit
300 MG
Pentamidine non-comp unit
ASP payment limit
$67.047
October 2026; -8.2% vs July 2026
Practitioner MUE
1
MAI 3
OPPS status
SI B
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J2545 is the Level II code for Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg, billed per 300 MG. The Medicare Part B ASP payment limit for October 2026 is $67.047 per billing unit, down 8.2% from July 2026. The practitioner MUE allows up to 1 units per date of service (MAI 3), so a full 1-unit day is $67.05 at the current limit. Under OPPS it carries status indicator B. J2545 is billed in units of 300 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names pentamidine isethionate: J2516 (billed per 1 mg). The ASP crosswalk maps 3 NDCs to it, sold as Pentamidine Isethionate, Nebupent by Seton Pharmaceuticals, XGen Pharmaceuticals DJB, Inc., FreseniUS Kabi USA, LLC. No current Billing and Coding Article lists J2545, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2545 at $67.047 per 300 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $72.997 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2545
QuarterPayment limitPerCoinsurance
October 2026$67.047300 MG20%
July 2026$72.997300 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 3 NDCs from 3 labelers to J2545. Report the NDC in the claim's drug segment and bill the number of J2545 units that equals the quantity administered divided by 300 MG; the last column gives units per full package.

NDCs that crosswalk to J2545
NDCDrug nameLabelerPackage sizeBilling units / package
13925-0522-01Pentamidine IsethionateSeton Pharmaceuticals1 × 11
39822-3030-02Pentamidine IsethionateXGen Pharmaceuticals DJB, Inc.1 × 11
63323-0877-15NebupentFreseniUS Kabi USA, LLC1 × 11

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J2545. For practitioners the limit is 1 unit per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J2545 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services13 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital13 Date of Service Edit: ClinicalPrescribing Information
DME supplier33 Date of Service Edit: ClinicalPrescribing Information

MUE for J2545 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

Medicaid NCCI differs: the 2026 Q4 Medicaid MUE for J2545 is 1 unit for DME supplier claims (Medicare: 3). Compare both programs in the MUE lookup or read how Medicaid NCCI differs from Medicare.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J2545 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J2545 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J2545 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J2545 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Local coverage policies that list J2545

1 active Local Coverage Determination lists J2545 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J2545 carries status indicator B. The OPPS status indicator reference explains how status B is paid.

Common denials for J2545 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J2545

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J2545

What does HCPCS code J2545 describe?

J2545 is defined by CMS as "Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg". Each billing unit represents 300 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J2545 a CPT code?

No. J2545 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as pentamidine isethionate (Nebupent); CPT codes are five-character codes maintained by the AMA. On a Part B claim J2545 reports the drug itself in 300 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J2545 in October 2026?

The ASP-based payment limit is $67.047 per 300 MG, with 20% beneficiary coinsurance. The July 2026 limit was $72.997. Commercial payers use their own fee schedules.

How many units of J2545 can be billed per day?

The practitioner Medically Unlikely Edit is 1 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J2545?

The October 2026 ASP crosswalk lists 3 NDCs from 3 labelers: Pentamidine Isethionate (Seton Pharmaceuticals); Pentamidine Isethionate (XGen Pharmaceuticals DJB, Inc.); Nebupent (FreseniUS Kabi USA, LLC). For example NDC 13925-0522-01 (package size 1) equals 1 billing unit of J2545.

Does J2545 have NCCI bundling edits?

No active practitioner PTP pairs list J2545 as a column-1 or column-2 code in the v323r0 release.

J2545 vs J2516: what is the difference?

Both are HCPCS Level II codes whose descriptor names pentamidine isethionate. What sets J2516 apart: billed per 1 mg. J2545 is billed per 300 mg, limit $67.047, MUE 1; J2516 is billed per 1 mg, limit $0.482, MUE 600. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.